{"id":"bf-200-ala-3","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Skin irritation"},{"rate":"5-10%","effect":"Phototoxicity"},{"rate":"5-10%","effect":"Pruritus"}]},"_chembl":{"chemblId":"CHEMBL5903032","moleculeType":null,"molecularWeight":"429.31"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the enzyme 5-aminolevulinic acid (ALA) synthase, which is involved in the production of porphyrins. The porphyrins then accumulate in the skin cells and cause cell death, leading to the removal of the affected cells.","oneSentence":"BF-200 ALA 3% is a topical cream used to treat actinic keratosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:58:04.812Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Actinic keratosis"}]},"trialDetails":[{"nctId":"NCT06876038","phase":"PHASE2","title":"Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Boston","startDate":"2026-09","conditions":"Oral Cancer, Oral Cavity Cancer, Oral Leukoplakia","enrollment":65},{"nctId":"NCT07241585","phase":"NA","title":"Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)","status":"NOT_YET_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2026-05-01","conditions":"Nonmelanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma","enrollment":54},{"nctId":"NCT06417281","phase":"PHASE3","title":"Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2024-06-19","conditions":"5-aminolevulinic Acid, Malignant Glioma of Brain","enrollment":86},{"nctId":"NCT07038278","phase":"EARLY_PHASE1","title":"5-AminoLevulinic Acid Aided Resection Margins in Sarcoma","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-04-01","conditions":"Soft Tissue Sarcoma (STS)","enrollment":20},{"nctId":"NCT07076472","phase":"EARLY_PHASE1","title":"Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-14","conditions":"Progressive Glioblastoma, Recurrent Glioblastoma","enrollment":8},{"nctId":"NCT05662202","phase":"PHASE3","title":"Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2022-12-12","conditions":"Actinic Keratoses","enrollment":172},{"nctId":"NCT06623201","phase":"PHASE1","title":"Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas","status":"RECRUITING","sponsor":"Nathalie Zeitouni","startDate":"2024-10-07","conditions":"Basal Cell Carcinoma (BCC)","enrollment":20},{"nctId":"NCT03573401","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2018-09-25","conditions":"Superficial Basal Cell Carcinoma","enrollment":187},{"nctId":"NCT07306247","phase":"NA","title":"Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-01","conditions":"HPV-16/18, Photodynamic Therapy (PDT), LSIL, Low Grade Squamous Intraepithelial Lesion","enrollment":225},{"nctId":"NCT05080764","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2021-12-10","conditions":"Acne Vulgaris","enrollment":126},{"nctId":"NCT05020912","phase":"PHASE2","title":"Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2021-12-13","conditions":"Basal Cell Carcinoma","enrollment":28},{"nctId":"NCT04381806","phase":"PHASE1","title":"Phase I Study in Advanced Malignancies With 5-ALA","status":"SUSPENDED","sponsor":"Fox Chase Cancer Center","startDate":"2020-07-30","conditions":"Solid Tumor","enrollment":130},{"nctId":"NCT05804370","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)","status":"RECRUITING","sponsor":"NX Development Corp","startDate":"2024-05-30","conditions":"Ovarian Cancer","enrollment":170},{"nctId":"NCT04400539","phase":"PHASE2","title":"The IMmunotherapy Pleural 5-ALA PDT","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2022-05-09","conditions":"Mesotheliomas Pleural, Malignant Pleural Mesothelioma","enrollment":20},{"nctId":"NCT01811121","phase":"PHASE3","title":"MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2013-02","conditions":"Glioblastoma","enrollment":170},{"nctId":"NCT02191488","phase":"PHASE1","title":"ALA-induced PpIX Fluorescence During Brain Tumor Resection","status":"ACTIVE_NOT_RECRUITING","sponsor":"David W. Roberts","startDate":"2014-07","conditions":"Brain Tumors","enrollment":540},{"nctId":"NCT04815083","phase":"PHASE3","title":"Fluorescence Imaging of Carcinoma During Breast Conserving Surgery","status":"TERMINATED","sponsor":"SBI ALApharma Canada, Inc.","startDate":"2021-04-27","conditions":"Breast Neoplasm Female, Breast Cancer","enrollment":57},{"nctId":"NCT02691923","phase":"PHASE2","title":"Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker","status":"RECRUITING","sponsor":"David W. Roberts","startDate":"2016-03","conditions":"Brain Cancer","enrollment":30},{"nctId":"NCT07027670","phase":"PHASE2","title":"Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-02-01","conditions":"Cardiac Surgical Procedures, Coronary Artery Bypass, Aortic Valve Disease","enrollment":48},{"nctId":"NCT06160492","phase":"PHASE3","title":"Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)","status":"RECRUITING","sponsor":"Lee's Pharmaceutical Limited","startDate":"2025-04-14","conditions":"5-aminolevulinic Acid, Fluorescence-guided Resection","enrollment":144},{"nctId":"NCT06052033","phase":"NA","title":"Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2023-09-11","conditions":"HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection","enrollment":40},{"nctId":"NCT06678867","phase":"PHASE2","title":"The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours","status":"NOT_YET_RECRUITING","sponsor":"University College, London","startDate":"2025-03-25","conditions":"Brain Tumor","enrollment":80},{"nctId":"NCT04559685","phase":"EARLY_PHASE1","title":"Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma","status":"RECRUITING","sponsor":"Nader Sanai","startDate":"2021-03-15","conditions":"High Grade Glioma","enrollment":30},{"nctId":"NCT06039709","phase":"PHASE1","title":"Sonodynamic Therapy in Patients With Recurrent GBM","status":"RECRUITING","sponsor":"Shayan Moosa, MD","startDate":"2024-01-31","conditions":"Recurrent Glioblastoma, Glioblastoma Multiforme, GBM","enrollment":11},{"nctId":"NCT05060237","phase":"PHASE1","title":"Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2021-12-01","conditions":"Actinic Keratosis, Keratosis, Actinic, Keratosis","enrollment":112},{"nctId":"NCT05123534","phase":"PHASE2","title":"A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG","status":"SUSPENDED","sponsor":"SonALAsense, Inc.","startDate":"2022-08-12","conditions":"Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma","enrollment":15},{"nctId":"NCT06252727","phase":"PHASE1","title":"Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)","status":"WITHDRAWN","sponsor":"University of California, Davis","startDate":"2024-07","conditions":"Soft Tissue Sarcoma, Soft Tissue Sarcoma Adult","enrollment":""},{"nctId":"NCT05370508","phase":"PHASE1, PHASE2","title":"A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM","status":"TERMINATED","sponsor":"SonALAsense, Inc.","startDate":"2023-02-06","conditions":"Recurrent GBM","enrollment":8},{"nctId":"NCT04305470","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma","status":"COMPLETED","sponsor":"NX Development Corp","startDate":"2020-10-28","conditions":"Meningioma","enrollment":108},{"nctId":"NCT06418113","phase":"PHASE1","title":"Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma","status":"RECRUITING","sponsor":"Hospital San Carlos, Madrid","startDate":"2024-03-21","conditions":"Glioblastoma, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype","enrollment":12},{"nctId":"NCT01837225","phase":"","title":"ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging Devices","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2010-09","conditions":"Breast Cancer","enrollment":90},{"nctId":"NCT04164849","phase":"PHASE1, PHASE2","title":"Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid","status":"COMPLETED","sponsor":"University Hospital, Akershus","startDate":"2019-11-22","conditions":"Crohn Disease","enrollment":7},{"nctId":"NCT01128218","phase":"PHASE1, PHASE2","title":"A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors","status":"COMPLETED","sponsor":"Southern Illinois University","startDate":"2011-03","conditions":"Brain Neoplasms","enrollment":33},{"nctId":"NCT01502280","phase":"PHASE3","title":"Fluorescence-guided Surgery for Low- and High-grade Gliomas","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2010-11","conditions":"Glioma","enrollment":127},{"nctId":"NCT02124733","phase":"PHASE3","title":"Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2014-04","conditions":"Actinic Keratosis","enrollment":23},{"nctId":"NCT01966120","phase":"PHASE3","title":"Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2013-10","conditions":"Actinic Keratosis","enrollment":87},{"nctId":"NCT05850377","phase":"","title":"5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas","status":"NOT_YET_RECRUITING","sponsor":"Sociedad de Lucha Contra el Cáncer del Ecuador","startDate":"2023-06-01","conditions":"High Grade Glioma, Glioma, Glioma, Malignant","enrollment":90},{"nctId":"NCT04976049","phase":"","title":"Use of 5-Aminolevulinic Acid to Assess Bone and Tissue Profusion in Orthopaedic Infection Patients","status":"WITHDRAWN","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2021-08-13","conditions":"Trauma, Infection, Bone Fracture","enrollment":""},{"nctId":"NCT02698293","phase":"PHASE1","title":"PDT Plus Vitamin D3 for Anal Dysplasia","status":"WITHDRAWN","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2019-12-01","conditions":"Anal Dysplasia, Carcinoma in Situ","enrollment":""},{"nctId":"NCT02144077","phase":"PHASE3","title":"Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2014-01-28","conditions":"Basal Cell Carcinoma (BCC)","enrollment":281},{"nctId":"NCT05547516","phase":"NA","title":"Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2022-09-13","conditions":"Non-muscle-invasive Bladder Cancer","enrollment":140},{"nctId":"NCT04055688","phase":"","title":"Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-08-15","conditions":"Brain Tumor, Glioma","enrollment":20},{"nctId":"NCT04044898","phase":"PHASE1","title":"Pharmacokinetics and Safety of ALA in Acne Vulgaris","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2021-01-12","conditions":"Acne Vulgaris","enrollment":19},{"nctId":"NCT04542850","phase":"NA","title":"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19","status":"COMPLETED","sponsor":"Royal College of Surgeons in Ireland - Medical University of Bahrain","startDate":"2020-11-15","conditions":"SARS-CoV 2, COVID-19","enrollment":15},{"nctId":"NCT03022903","phase":"NA","title":"Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2015-09","conditions":"Toenail Onychomycosis, Distal and Lateral Subungual Toenail Onychomycosis","enrollment":2},{"nctId":"NCT04319159","phase":"PHASE1","title":"Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2020-03-05","conditions":"Actinic Keratoses","enrollment":48},{"nctId":"NCT04854876","phase":"NA","title":"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19","status":"WITHDRAWN","sponsor":"Royal College of Surgeons in Ireland - Medical University of Bahrain","startDate":"2021-08-15","conditions":"SARS-COV 2, Covid19","enrollment":""},{"nctId":"NCT00752323","phase":"PHASE2","title":"Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma","status":"COMPLETED","sponsor":"Andrew Sloan, MD","startDate":"2009-12-08","conditions":"Brain and Central Nervous System Tumors","enrollment":73},{"nctId":"NCT03638622","phase":"PHASE1, PHASE2","title":"Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer.","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-03-10","conditions":"Oral Cancer","enrollment":30},{"nctId":"NCT04709289","phase":"NA","title":"Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study","status":"COMPLETED","sponsor":"Shanghai Dermatology Hospital","startDate":"2020-01-01","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT04018885","phase":"PHASE1, PHASE2","title":"A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2019-07-11","conditions":"Acne Vulgaris","enrollment":72},{"nctId":"NCT04396184","phase":"NA","title":"Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis","status":"UNKNOWN","sponsor":"Shanghai Dermatology Hospital","startDate":"2020-05-01","conditions":"Actinic Keratosis","enrollment":10},{"nctId":"NCT04020653","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria","status":"WITHDRAWN","sponsor":"Neopharma Japan Co., Ltd.","startDate":"2019-09-06","conditions":"Malaria","enrollment":""},{"nctId":"NCT02631863","phase":"PHASE2","title":"Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2016-03-22","conditions":"Cervical Intraepithelial Neoplasia, Low-Grade Squamous Intraepithelial Lesions, Papillomavirus Infections","enrollment":60},{"nctId":"NCT00870779","phase":"PHASE1","title":"Fluorescence Guided Resection of Brain Tumors","status":"COMPLETED","sponsor":"David W. Roberts","startDate":"2007-05","conditions":"Brain Tumors","enrollment":105},{"nctId":"NCT03948321","phase":"NA","title":"Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts","status":"UNKNOWN","sponsor":"Shanghai Dermatology Hospital","startDate":"2019-05-10","conditions":"Genital Warts","enrollment":20},{"nctId":"NCT03961607","phase":"NA","title":"Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Moderate or Severe Acne","status":"UNKNOWN","sponsor":"Shanghai Dermatology Hospital","startDate":"2019-05-10","conditions":"Acne","enrollment":20},{"nctId":"NCT00961090","phase":"PHASE2","title":"Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery","status":"COMPLETED","sponsor":"Matthew R Quigley","startDate":"2009-09","conditions":"Glioblastoma","enrollment":72},{"nctId":"NCT02367547","phase":"PHASE1, PHASE2","title":"Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL","status":"UNKNOWN","sponsor":"Joint Authority for Päijät-Häme Social and Health Care","startDate":"2015-03","conditions":"Neoplasms, Basal Cell, Carcinoma, Basal Cell, Photochemotherapy","enrollment":117},{"nctId":"NCT03642535","phase":"PHASE4","title":"Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention","status":"UNKNOWN","sponsor":"Shanghai Dermatology Hospital","startDate":"2018-08-30","conditions":"Actinic Keratoses","enrollment":300},{"nctId":"NCT02632370","phase":"","title":"5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor","status":"COMPLETED","sponsor":"Constantinos Hadjipanayis","startDate":"2016-05","conditions":"Malignant Gliomas","enrollment":69},{"nctId":"NCT00814528","phase":"NA","title":"Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2007-11","conditions":"Actinic Keratosis","enrollment":""},{"nctId":"NCT02239679","phase":"PHASE2","title":"Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2014-09","conditions":"Actinic Keratosis","enrollment":166},{"nctId":"NCT02685592","phase":"PHASE4","title":"Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream","status":"COMPLETED","sponsor":"Joint Authority for Päijät-Häme Social and Health Care","startDate":"2016-02","conditions":"Lentigo Maligna","enrollment":10},{"nctId":"NCT03024060","phase":"PHASE3","title":"Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp","status":"WITHDRAWN","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2017-03","conditions":"Actinic Keratosis","enrollment":""},{"nctId":"NCT02628236","phase":"PHASE2","title":"Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2016-02","conditions":"Keratosis, Actinic","enrollment":14},{"nctId":"NCT02622594","phase":"PHASE4","title":"Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times","status":"COMPLETED","sponsor":"Dermatology, Laser & Vein Specialists of the Carolinas","startDate":"2015-10","conditions":"Actinic Keratoses","enrollment":10},{"nctId":"NCT01459393","phase":"PHASE3","title":"Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment","status":"COMPLETED","sponsor":"Barretos Cancer Hospital","startDate":"2010-11","conditions":"Actinic Keratosis","enrollment":137},{"nctId":"NCT00524485","phase":"NA","title":"Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2005-05","conditions":"Precancerous/Nonmalignant Condition","enrollment":12},{"nctId":"NCT02799069","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2008-04","conditions":"Actinic Keratosis","enrollment":571},{"nctId":"NCT02799082","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2007-12","conditions":"Actinic Keratosis","enrollment":122},{"nctId":"NCT03025724","phase":"NA","title":"Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ","status":"UNKNOWN","sponsor":"Rhode Island Hospital","startDate":"2017-01","conditions":"Squamous Cell Carcinoma","enrollment":40},{"nctId":"NCT02281136","phase":"PHASE2","title":"Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2014-12","conditions":"Keratosis, Actinic","enrollment":29},{"nctId":"NCT02119338","phase":"NA","title":"5-ALA in Recurrent Glioma","status":"UNKNOWN","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2014-02","conditions":"Glioma","enrollment":60},{"nctId":"NCT01475955","phase":"PHASE2","title":"Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2011-12","conditions":"Actinic Keratosis","enrollment":235},{"nctId":"NCT02209012","phase":"","title":"Twelve Month Follow-Up of CP0108","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2014-08","conditions":"Actinic Keratosis","enrollment":206},{"nctId":"NCT02799030","phase":"PHASE2","title":"A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2006-10","conditions":"Actinic Keratosis","enrollment":105},{"nctId":"NCT02755142","phase":"PHASE1, PHASE2","title":"Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas","status":"COMPLETED","sponsor":"medac GmbH","startDate":"2000-02","conditions":"Brain Neoplasm","enrollment":21},{"nctId":"NCT01445691","phase":"PHASE2","title":"More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery","status":"WITHDRAWN","sponsor":"Constantinos Hadjipanayis","startDate":"2015-11","conditions":"Benign Neoplasms, Brain, Brain Cancer, Brain Neoplasms, Benign","enrollment":""},{"nctId":"NCT01351519","phase":"PHASE2","title":"A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors","status":"TERMINATED","sponsor":"MultiCare Health System Research Institute","startDate":"2011-05","conditions":"Malignant Glioma, Glioma, Glioblastoma","enrollment":16},{"nctId":"NCT02647151","phase":"PHASE4","title":"Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel","status":"UNKNOWN","sponsor":"Fundación Instituto Valenciano de Oncología","startDate":"2015-12","conditions":"Actinic Keratosis","enrollment":50},{"nctId":"NCT02137785","phase":"PHASE3","title":"Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2014-05","conditions":"Actinic Keratosis","enrollment":269},{"nctId":"NCT00814918","phase":"NA","title":"Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":""},{"nctId":"NCT00571558","phase":"PHASE1","title":"Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-03","conditions":"Oral Leukoplakia","enrollment":15},{"nctId":"NCT02050243","phase":"PHASE1, PHASE2","title":"The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2014-02","conditions":"Central Nervous System Tumor, Pediatric","enrollment":100},{"nctId":"NCT01898416","phase":"PHASE2","title":"Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors","status":"RECRUITING","sponsor":"michal roll","startDate":"2013-06","conditions":"The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an, Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After, Surgical Resection","enrollment":140},{"nctId":"NCT01458587","phase":"PHASE2","title":"Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2011-11","conditions":"Keratosis, Actinic","enrollment":70},{"nctId":"NCT01697670","phase":"PHASE1","title":"Photodynamic Therapy for Ulcerative Colitis","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2012-09","conditions":"Ulcerative Colitis","enrollment":7},{"nctId":"NCT01167322","phase":"PHASE3","title":"Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2010-08","conditions":"Malignant Glioma","enrollment":45},{"nctId":"NCT00706433","phase":"PHASE2","title":"Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2007-03","conditions":"Acne Vulgaris","enrollment":266},{"nctId":"NCT00671710","phase":"PHASE1","title":"Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain","status":"COMPLETED","sponsor":"Advocate Hospital System","startDate":"2008-04","conditions":"Brain Tumors","enrollment":26}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BF-200 ALA 3%","genericName":"BF-200 ALA 3%","companyName":"Biofrontera Bioscience GmbH","companyId":"biofrontera-bioscience-gmbh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BF-200 ALA 3% is a topical cream used to treat actinic keratosis. Used for Actinic keratosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}